Follow
Dr. Ritika Kondel Bhandari
Dr. Ritika Kondel Bhandari
Scientist D, ICMR-PGIMER project, Chandigarh, India
No verified email
Title
Cited by
Cited by
Year
Effect of acyclovir solid lipid nanoparticles for the treatment of herpes simplex virus (HSV) infection in an animal model of HSV-1 infection
R Kondel, N Shafiq, IP Kaur, MP Singh, AK Pandey, RK Ratho, S Malhotra
Pharmaceutical Nanotechnology 7 (5), 389-403, 2019
302019
A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India
AM Panditrao, N Shafiq, S Chatterjee, A Pathak, N Trivedi, B Sadasivam, ...
Journal of Antimicrobial Chemotherapy 76 (4), 1094-1101, 2021
102021
Assessment of Appropriateness of Antimicrobial Therapy in Resource-Constrained Settings: Development and Piloting of a Novel Tool—AmRAT
AK Kakkar, N Shafiq, N Sahni, R Mohindra, N Kaur, N Gamad, ...
Antibiotics 10 (2), 200, 2021
72021
Feasibility and efficacy of gentamicin for treating neonatal sepsis in community-based settings: a systematic review
N Jaiswal, M Singh, R Kondel, N Kaur, KK Thumburu, A Kumar, H Kaur, ...
World Journal of Pediatrics 12, 408-414, 2016
72016
Pharmacokinetic and pharmacodynamic evaluation of nano-fixed dose combination for hypertension
AK Pandey, N Shafiq, RK Bhandari, IIG Rather, N Kaur, A Bhatia, ...
Journal of Hypertension 38 (8), 1593-1602, 2020
52020
Colistin disposition in the cerebrospinal fluid when administered either intravenously alone or with intraventricular/intrathecally in neonates/pediatric patients with culture …
RK Bhandari, AK Pandey, N Shafiq, J Kumar, S Malhotra, C Mothsara, ...
Pediatrics & Neonatology 63 (2), 190-191, 2022
42022
Tuberculosis and Nanotechnology: Where shall the Twain meet?
N Shafiq, R Kondel, S Malhotra
Journal of Postgraduate Medicine, Education and Research 47 (4), 188, 2013
42013
In vitro and in vivo evaluation of clastogenicity of second-line antitubercular drug loaded PLGA nanoparticles
AK Pandey, R Kumar, N Shafiq, R Kondel, S Garg, H Negi, SK Arora, ...
Human & Experimental Toxicology 40 (7), 1064-1073, 2021
32021
A study to explore the appropriateness of dosing regimen of vancomycin in critically ill patients in a tertiary care unit of India
D Belavagi, RK Bhandari, N Shafiq, V Gota, A Patil, AK Pandey, ...
Germs 12 (2), 238, 2022
22022
Effect of atorvastatin nanoparticles compared to free atrovastatin on plaque properties in rabbit model of atherosclerosis
BA Arora A, Bhandari RK, Pandey AK, Rather II, Malhotra S
Int J Non-Commun Dis 4, 127-31, 2019
2*2019
A pilot study to assess for mislabelling of drug samples with regards to amount of active ingredient
R Kondel, AK Pandey, A Arora, N Shafiq, S Malhotra
Int J Pharm Res Sch 3 (2), 449-452, 2014
22014
Anti-tubercular therapy (ATT) induced thrombocytopenia: A systematic review
A Kaur, RK Bhandari, R Rohilla, N Shafiq, G Prakash, C Mothsara, ...
Indian Journal of Tuberculosis, 2023
12023
Population pharmacokinetics of ciprofloxacin in newborns with early onset neonatal sepsis and suspected meningitis
K Garg, RK Bhandari, N Shafiq, S Jain, S Jaswal, D Chawla, ...
Pediatric Research 95 (5), 1273-1278, 2024
2024
Bio‐evaluation of poly (lactic‐co‐glycolic) acid nanoparticles loaded with radiolabelled rifampicin
I Rather, N Shafiq, J Shukla, G Kaur, S Pandey, RK Bhandari, AK Pandey, ...
British Journal of Clinical Pharmacology 89 (12), 3702-3714, 2023
2023
Antibiotic Prophylaxis for Orthopaedic Implant Removal: What Does the Evidence Say?
IIG Rather, N Shafiq, AK Pandey, RK Bhandari, S Malhotra, DK Chouhan
Current Drug Safety 18 (1), 116-120, 2023
2023
Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers
H Khera, AK Pandey, N Shafiq, GK Khuller, R Kondel Bhandari, ...
Expert Review of Anti-infective Therapy 20 (6), 955-961, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–16